0
01/07/2024
30/06/2025
2025-06-30
false
false
false
false
true
false
false
false
false
false
true
false
false
true
true
false
false
false
true
true
false
2024-07-01
Sage Accounts Production 25.0 - FRS102_2024
xbrli:pure
xbrli:shares
iso4217:GBP
10623878
2024-07-01
2025-06-30
10623878
2025-06-30
10623878
2024-06-30
10623878
2023-07-01
2024-06-30
10623878
2024-06-30
10623878
2023-06-30
10623878
bus:OrdinaryShareClass1
2024-07-01
2025-06-30
10623878
bus:LeadAgentIfApplicable
2024-07-01
2025-06-30
10623878
bus:Director1
2024-07-01
2025-06-30
10623878
core:WithinOneYear
2025-06-30
10623878
core:WithinOneYear
2024-06-30
10623878
core:ShareCapital
2025-06-30
10623878
core:ShareCapital
2024-06-30
10623878
core:RetainedEarningsAccumulatedLosses
2025-06-30
10623878
core:RetainedEarningsAccumulatedLosses
2024-06-30
10623878
bus:OrdinaryShareClass1
core:ShareCapital
2025-06-30
10623878
bus:OrdinaryShareClass1
core:ShareCapital
2024-06-30
10623878
core:CostValuation
core:Non-currentFinancialInstruments
2024-06-30
10623878
core:DisposalsRepaymentsInvestments
core:Non-currentFinancialInstruments
2025-06-30
10623878
core:Non-currentFinancialInstruments
core:OtherIncreaseDecreaseInInvestments
2025-06-30
10623878
core:CostValuation
core:Non-currentFinancialInstruments
2025-06-30
10623878
core:Non-currentFinancialInstruments
core:ProvisionsForImpairmentInvestments
2024-06-30
10623878
core:ImpairmentLossProvisionsForImpairmentInvestments
core:Non-currentFinancialInstruments
2025-06-30
10623878
core:ImpairmentReversalProvisionsForImpairmentInvestments
core:Non-currentFinancialInstruments
2025-06-30
10623878
core:Non-currentFinancialInstruments
core:ProvisionsForImpairmentInvestments
2025-06-30
10623878
core:Non-currentFinancialInstruments
2025-06-30
10623878
core:Non-currentFinancialInstruments
2024-06-30
10623878
bus:SmallEntities
2024-07-01
2025-06-30
10623878
bus:Audited
2024-07-01
2025-06-30
10623878
bus:SmallCompaniesRegimeForAccounts
2024-07-01
2025-06-30
10623878
bus:PrivateLimitedCompanyLtd
2024-07-01
2025-06-30
10623878
bus:FullAccounts
2024-07-01
2025-06-30
10623878
core:WithinOneYear
2024-07-01
2025-06-30
10623878
1
2024-07-01
2025-06-30
10623878
core:OtherRelatedParties
core:OtherTransactionType1
2024-07-01
2025-06-30
Company registration number:
10623878
Hirize Limited
Filleted financial statements
30 June 2025
Hirize Limited
Contents
Statement of financial position
Notes to the financial statements
Hirize Limited
Statement of financial position
30 June 2025
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
Note |
£ |
|
£ |
|
£ |
|
£ |
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
|
|
|
|
|
|
|
|
Investments |
|
5 |
56,138 |
|
|
|
62,826 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
56,138 |
|
|
|
62,826 |
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
Listed securities & options held for resale |
|
|
2,246,681 |
|
|
|
1,669,255 |
|
|
|
Cash at bank and in hand |
|
|
126,710 |
|
|
|
201,467 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
2,373,391 |
|
|
|
1,870,722 |
|
|
|
Creditors: amounts falling due |
|
|
|
|
|
|
|
|
|
|
within one year |
|
6 |
(
2,355,722) |
|
|
|
(
1,893,772) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
Net current assets/(liabilities) |
|
|
|
|
17,669 |
|
|
|
(
23,050) |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Total assets less current liabilities |
|
|
|
|
73,807 |
|
|
|
39,776 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Net assets |
|
|
|
|
73,807 |
|
|
|
39,776 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
|
|
|
|
Called up share capital |
|
7 |
|
|
100 |
|
|
|
100 |
|
Profit and loss account |
|
8 |
|
|
73,707 |
|
|
|
39,676 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
Shareholders funds |
|
|
|
|
73,807 |
|
|
|
39,776 |
|
|
|
|
|
_______ |
|
|
|
_______ |
|
|
|
|
|
|
|
|
|
|
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the
board of directors
and authorised for issue on
03 June 2026
, and are signed on behalf of the board by:
Mr Amin Merali
Director
Company registration number:
10623878
Hirize Limited
Notes to the financial statements
Year ended 30 June 2025
1.
General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is 7 Greenock Road, Acton, London, W3 8DU.
The principal activity of the company is that of trading in securities and options. The secondary activity is that of indirectly investing in entities dealing with building developments.
2.
Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', and the Companies Act 2006.
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and fixed asset investments measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The Directors have assessed the Company's ability to continue as a going concern, taking into account the current macroeconomic environment, including geopolitical uncertainties, inflationary pressures and volatility in energy and commodity markets. The Directors have considered the potential impact of these factors on the Company's financial position, liquidity and forecast trading performance.In forming their judgement, the Directors have reviewed the Company's cash resources, liquidity headroom and financial forecasts. The assessment has also taken into account the group reorganisation completed on 1 April 2026, as described in note 10, including the demerger of part of the holdings of Treats Holdings Ltd, the transfer of subsidiaries and the waiver of an intercompany loan.Based on the forecasts prepared, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on a going concern basis.
Disclosure exemptions
The company satisfies the criteria of being a qualifying entity as defined in FRS 102. Its financial statements are consolidated into the financial statements of Treats Holdings Limited which can be obtained from the Registrar of Companies (England and Wales), Companies House, Cardiff. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS102:(a) No cash flow statement has been presented for the company.(b) Disclosures in respect of financial instruments have not been presented.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgments are continually reviewed and are based on the experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents proceeds from sale of listed securities and options, income from loan investments and other equity investments.Revenue is recognised when the significant risks and rewards of ownership have transferred and the amount of revenue can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to profit or loss.
Fixed asset investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Listed securities and options held for resale
Listed securities and options are measured at the lower of cost and estimated selling price less costs to sell. Estimated selling price is the closing price of the listed securities and options from stock market at the year end date.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4.
Employee numbers
There were no employees during the year other than the directors.
5.
Investments
|
|
Other investments other than loans |
Other loans |
Total |
|
|
£ |
£ |
£ |
|
Cost |
|
|
|
|
At 1 July 2024 |
129,086 |
203,750 |
332,836 |
|
Other equity investments written off |
(
110,539) |
- |
(
110,539) |
|
Non trading loan written off |
- |
(
127,222) |
(
127,222) |
|
|
_______ |
_______ |
_______ |
|
At 30 June 2025 |
18,547 |
76,528 |
95,075 |
|
|
_______ |
_______ |
_______ |
|
Impairment |
|
|
|
|
At 1 July 2024 |
122,798 |
147,212 |
270,010 |
|
Impairment loss |
729 |
1,758 |
2,487 |
|
Reversal of impairment loss |
(
110,602) |
(
122,958) |
(
233,560) |
|
|
_______ |
_______ |
_______ |
|
At 30 June 2025 |
12,925 |
26,012 |
38,937 |
|
|
_______ |
_______ |
_______ |
|
Carrying amount |
|
|
|
|
At 30 June 2025 |
5,622 |
50,516 |
56,138 |
|
|
_______ |
_______ |
_______ |
|
At 30 June 2024 |
6,288 |
56,538 |
62,826 |
|
|
_______ |
_______ |
_______ |
|
|
|
|
|
Included above are investments in two companies which have been dissolved. Equity investments in the sum of of £110,539 and non trading loans amounting £127,222 relating to these two dissolved companies have been written off in the financial statements.
6.
Creditors: amounts falling due within one year
|
|
|
2025 |
2024 |
|
|
|
£ |
£ |
|
Other loan |
|
845,792 |
313,421 |
|
Amounts owed to group undertakings |
|
1,502,682 |
1,502,682 |
|
Corporation tax |
|
- |
72,269 |
|
Other creditors |
|
7,248 |
5,400 |
|
|
|
_______ |
_______ |
|
|
|
2,355,722 |
1,893,772 |
|
|
|
_______ |
_______ |
|
|
|
|
|
The amount owed to group undertakings is unsecured, interest free and repayable on demand.The amount shown under Other loan is repayable on demand, interest bearing and is secured against the Listed securities and options held for resale.
7.
Called up share capital
Issued, called up and fully paid
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
|
No |
|
£ |
|
No |
|
£ |
|
Ordinary shares of £
1.00 each |
|
100 |
|
100 |
|
100 |
|
100 |
|
|
|
_______ |
|
_______ |
|
_______ |
|
_______ |
|
|
|
|
|
|
|
|
|
|
8.
Reserves
Profit and loss account:This reserve records retained earnings and accumulated losses.
9.
Events after the end of the reporting period
Between 30 March and 1 April 2026, the Group undertook a reorganisation which resulted in a demerger of part of the holdings of the Parent company, Treats Holdings Ltd. As part of this reorganisation:1. Transfer of subsidiaryThe Parent company's entire investment in Hirize Ltd was transferred to a newly incorporated holding company, Hirize Holdings Ltd, whose shareholders mirror those of Treats Holdings Ltd. This transaction formed part of a wider group restructuring and occurred after the reporting date. It is therefore a non adjusting event under FRS 102.2. Loan waiverTreats Holdings Ltd waived a loan payable by the Company with a balance of£1,502,682 at the date of waiver. As the waiver occurred after the reporting date, it is a non adjusting event under FRS 102.Management has assessed the impact of these events and concluded that they do not affect the Company's ability to continue as a going concern. The financial statements for the year ended 30 June 2025 have not been adjusted for these transactions.
10.
Summary audit opinion
The auditor's report dated
03 June 2026
was unqualified.
The senior statutory auditor was
Bharatkumar L Shah
for and on behalf of
Anderson Shaw
11.
Related party transactions
The company is exempt from the requirement to disclose transactions with other group companies on the grounds that all of its voting rights are controlled by Treats Holdings Limited and the company's results are consolidated within the financial statements of Treats Holdings Limited.
12.
Controlling party
As at 30 June 2025, Treats Holdings Limited, a company incorporated in England and Wales, was the ultimate holding company.
In the opinion of the directors, Mr A Merali controls the company.
13.
Comparative figures
Comparative figures have been reclassified where necessary to comform with changes in presentation in the current year.